TipRanks
Advertisement
Advertisement

GRAL Stock Latest News

Uxin, Greenland Mines, Streamex, GRAIL Inc, VCI Global
Weekend UpdatesUxin, Greenland Mines, Streamex, GRAIL Inc, VCI Global
17h ago
GRAL
GRML
Grail price target raised to $175 from $105 at UBS
PremiumThe Fly
Grail price target raised to $175 from $105 at UBS
9d ago
GRAL
Grail price target raised to $155 from $75 at Guggenheim
PremiumThe Fly
Grail price target raised to $155 from $75 at Guggenheim
10d ago
GRAL
Grail price target raised to $150 from $80 at Canaccord
PremiumThe Fly
Grail price target raised to $150 from $80 at Canaccord
13d ago
GRAL
Grail price target raised to $100 from $65 at Mizuho
PremiumThe Fly
Grail price target raised to $100 from $65 at Mizuho
16d ago
GRAL
Midday Fly By: Meta unveils Muse products, Starbucks to close 250 stores
PremiumThe FlyMidday Fly By: Meta unveils Muse products, Starbucks to close 250 stores
17d ago
P
BB
Grail panel votes ‘closer than we expected,’ says BTIG
Premium
The Fly
Grail panel votes ‘closer than we expected,’ says BTIG
17d ago
GH
ABT
AdCom meeting for Grail’s Galleri test better than expected, says Canaccord
Premium
The Fly
AdCom meeting for Grail’s Galleri test better than expected, says Canaccord
17d ago
GRAL
TD ups Grail approval probability to 95% after panel vote
PremiumThe Fly
TD ups Grail approval probability to 95% after panel vote
17d ago
GRAL
Grail says FDA panel recommendations ‘reaffirm high evidence bar’ for Galleri
PremiumThe Fly
Grail says FDA panel recommendations ‘reaffirm high evidence bar’ for Galleri
17d ago
GRAL
FDA panel votes in favor of Grail’s Galleri benefits outweighing risks
PremiumThe Fly
FDA panel votes in favor of Grail’s Galleri benefits outweighing risks
17d ago
GRAL
Grail wins FDA panel backing for blood test to detect cancer, Bloomberg says
PremiumThe Fly
Grail wins FDA panel backing for blood test to detect cancer, Bloomberg says
17d ago
GRAL
FDA panel votes 6-4 that Grail’s Galleri test is effective, Bloomberg says
PremiumThe FlyFDA panel votes 6-4 that Grail’s Galleri test is effective, Bloomberg says
17d ago
GRAL
FDA panel says Grail’s cancer detection blood test is safe, Bloomberg says
Premium
The Fly
FDA panel says Grail’s cancer detection blood test is safe, Bloomberg says
17d ago
GRAL
Grail price target raised to $118 from $86 at Baird
Premium
The Fly
Grail price target raised to $118 from $86 at Baird
19d ago
GRAL
Grail FDA briefing documents ‘amicable’ to approval, says Mizuho
PremiumThe Fly
Grail FDA briefing documents ‘amicable’ to approval, says Mizuho
19d ago
GRAL
Hold Rating Reaffirmed as Regulatory Upside Seen Largely Priced In, with Price Target Maintained at $60
PremiumRatings
Hold Rating Reaffirmed as Regulatory Upside Seen Largely Priced In, with Price Target Maintained at $60
19d ago
GRAL
Grail rises 37.4%
PremiumThe Fly
Grail rises 37.4%
20d ago
GRAL
Grail rallies after FDA releases briefing documents for Galleri test review
PremiumThe Fly
Grail rallies after FDA releases briefing documents for Galleri test review
20d ago
GRAL
Grail rises 23.2%
PremiumThe FlyGrail rises 23.2%
20d ago
GRAL
Why Is GRAIL Stock (GRAL) Up 22% Today?
Premium
Market News
Why Is GRAIL Stock (GRAL) Up 22% Today?
20d ago
GRAL
Grail initiated with a Sector Perform at RBC Capital
Premium
The Fly
Grail initiated with a Sector Perform at RBC Capital
24d ago
GRAL

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >